Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1993-9-9
|
pubmed:abstractText |
The transport of 5-fluorouracil (5-FU) and uracil into human erythrocytes has been investigated under initial velocity conditions with an "inhibitor-stop" assay using a cold papaverine solution to terminate influx. At 37 degrees and pH 7.3, 5-FU influx was nonconcentrative; was partially inhibited by adenine, hypoxanthine, thymine, and uracil; and was insensitive to inhibition by nucleosides or inhibitors of nucleoside transport. Inhibition of the influx of 5-FU or uracil by adenine (3.0 mM) did not increase when other pyrimidines or inhibitors of nucleoside transport were combined with adenine. 5-FU and uracil exhibited similar saturable (Km approximately 4 mM, Vmax approximately 500 pmol/sec/5 microL cells) and nonsaturable (rate constant approximately 80 pmol/sec/mM/5 microL cells) components of influx. 5-FU, uracil, adenine, and hypoxanthine were competitive inhibitors of each other's influx with Ki values matching their respective Km values for influx. We conclude that 5-FU and uracil enter human erythrocytes at similar rates via both nonfacilitated diffusion and the same carrier that transports adenine and hypoxanthine.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adenine,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil,
http://linkedlifedata.com/resource/pubmed/chemical/Hypoxanthine,
http://linkedlifedata.com/resource/pubmed/chemical/Hypoxanthines,
http://linkedlifedata.com/resource/pubmed/chemical/Nucleic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Nucleosides,
http://linkedlifedata.com/resource/pubmed/chemical/Papaverine,
http://linkedlifedata.com/resource/pubmed/chemical/Tritium,
http://linkedlifedata.com/resource/pubmed/chemical/Uracil
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0006-2952
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
3
|
pubmed:volume |
46
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
503-10
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8347174-Adenine,
pubmed-meshheading:8347174-Biological Transport,
pubmed-meshheading:8347174-Erythrocytes,
pubmed-meshheading:8347174-Fluorouracil,
pubmed-meshheading:8347174-Humans,
pubmed-meshheading:8347174-Hypoxanthine,
pubmed-meshheading:8347174-Hypoxanthines,
pubmed-meshheading:8347174-Kinetics,
pubmed-meshheading:8347174-Nucleic Acids,
pubmed-meshheading:8347174-Nucleosides,
pubmed-meshheading:8347174-Papaverine,
pubmed-meshheading:8347174-Tritium,
pubmed-meshheading:8347174-Uracil
|
pubmed:year |
1993
|
pubmed:articleTitle |
Transport of 5-fluorouracil and uracil into human erythrocytes.
|
pubmed:affiliation |
Division of Experimental Therapy, Wellcome Research Laboratories, Research Triangle Park, NC 27709.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|